Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.47 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.47 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.45 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | PTGES | O14684 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.43 |
| ▸ | GHSR | Q92847 | 1/20 | 0.43 |
| ▸ | PLK1 | P53350 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7083101 | 1.00 | PTGER4 (0.47) | PTGER4PTGER3PTGER2PPARATHRB | |
| SCHEMBL2489078 | 1.00 | PTGER4 (0.47) | PTGER4PTGER3PTGER2PPARATHRB | |
| SCHEMBL39939 | 1.00 | PTGER4 (0.47) | PTGER4PTGER3PTGER2PPARATHRB | |
| SCHEMBL5150459 | 0.99 | PTGER4 (0.48) | PTGER4PTGER3PTGER2PPARATHRB | |
| SCHEMBL2490381 | 0.99 | PTGER4 (0.48) | PTGER4PTGER3PTGER2PPARATHRB | |
| SCHEMBL5178122 | 0.95 | PTGER4 (0.49) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL6367849 | 0.95 | PTGER4 (0.49) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL489473 | 0.89 | PTGER4 (0.51) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL489472 | 0.89 | PTGER4 (0.51) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL27733390 | 0.89 | PLA2G2D (0.42) | PPARATHRBESR1ESR2PLA2G2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 906 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250107974-A1 | MICROCAPSULES COMPRISING SUNSCREEN AGENTS | TAGRA BIOTECHNOLOGIES LTD. (IL) | 2025-04-03 | — | — | US | claimed |
| US-11992545-B2 | Aqueous cosmetic compositions containing pelargonic acid esters | NOVAMONT S.P.A. (IT) | 2024-05-28 | — | — | US | claimed |
| WO-2024008902-A1 | ANTI-AGEING COSMETIC CARE COMPOSITION COMPRISING CAULERPIN | B.R. (BIOLOGIQUE RECHERCHE) (FR) | 2024-01-11 | — | — | WO | claimed |
| EP-3797756-A1 | SUNSCREEN AGENT USING CELLULOSE NANOFIBERS | Nature Costech Co., Ltd. (KR) | 2021-03-31 | — | — | EP | claimed |
| EP-3122321-B1 | PHOTOSTABLE SUNSCREEN COMPOSITION FOR TOPICAL APPLICATION | KANCOR INGREDIENTS LTD (IN) | 2020-10-14 | — | — | EP | claimed |
| EP-2942045-B1 | Bead-shaped cosmetic dosage forms | BEIERSDORF AG (DE) | 2018-10-10 | — | — | EP | claimed |
| EP-2847784-B1 | POLISHING PAD WITH LIGHT-STABLE LIGHT-TRANSMITTING REGION | CABOT MICROELECTRONICS CORP (US) | 2017-07-05 | — | — | EP | claimed |
| US-20170065510-A1 | PHOTOSTABLE SUNSCREEN COMPOSITION FOR TOPICAL APPLICATION | KANCOR INGREDIENTS LTD (IN) | 2017-03-09 | — | — | US | claimed |
| EP-3122321-A2 | PHOTOSTABLE SUNSCREEN COMPOSITION FOR TOPICAL APPLICATION | Kancor Ingredients Ltd (IN) | 2017-02-01 | — | — | EP | claimed |
| US-20160008237-A1 | MICROCAPSULES COMPRISING SUNSCREEN AGENTS | TAGRA BIOTECHNOLOGIES LTD. (IL) | 2016-01-14 | — | — | US | claimed |
| US-20090029480-A1 | Testing device | VERITEQUE USA, INC. | 2009-01-29 | — | — | US | claimed |
| WO-2006108003-A1 | TRANSLUCENT, SUNSCREENING COSMETIC FOUNDATION COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2006-10-12 | — | — | WO | claimed |
| EP-1709954-A1 | Translucent, sunscreening cosmetic foundation composition | THE PROCTER & GAMBLE COMPANY (US) | 2006-10-11 | — | — | EP | claimed |
| US-20060222606-A1 | Translucent, sunscreening cosmetic foundation composition | PROCTER & GAMBLE COMPANY, THE | 2006-10-05 | — | — | US | claimed |
| US-7115674-B2 | Dental self-curing resin cement compositions | DENTKIST, INC. (KR) | 2006-10-03 | — | — | US | claimed |
| US-20050049326-A1 | Dental self-curing resin cement compositions | DENTKIST, INC. (KR) | 2005-03-03 | — | — | US | claimed |
| US-6090369-A | Sunscreen formulation with avobenzone and method for stabilizing sunscreen formulation which contains avobenzone | IGUANA, LLC | 2000-07-18 | — | — | US | claimed |
| EP-0492007-B1 | Process for producing liquid loaded powders | FAULDING F H & CO LTD (AU) | 1995-02-08 | — | — | EP | claimed |
| US-5209923-A | Sunscreen composition | MOLECULON, INC. (US) | 1993-05-11 | — | — | US | claimed |
| EP-0492007-A1 | Process for producing liquid loaded powders | F.H. FAULDING & CO. LIMITED (AU) | 1992-07-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250107974-A1 | MICROCAPSULES COMPRISING SUNSCREEN AGENTS | CUTA, HSF1, MITF | PTGER4 4505/4885PTGER3 4565/4885PTGER2 4491/4885 |
| US-20160008237-A1 | MICROCAPSULES COMPRISING SUNSCREEN AGENTS | CUTA, HSF1, MITF | PTGER4 4505/4885PTGER3 4565/4885PTGER2 4491/4885 |
| US-20060222606-A1 | Translucent, sunscreening cosmetic foundation composition | LBR, CUTA, TLL2 | PTGER4 3309/4885PTGER3 3346/4885PTGER2 2547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.